3 false false true false false false false false false false true false false false false false false No description of principal activity 2024-01-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 07318073 2024-01-01 2024-12-31 07318073 2024-12-31 07318073 2023-12-31 07318073 2023-01-01 2023-12-31 07318073 2023-12-31 07318073 2022-12-31 07318073 core:PlantMachinery 2024-01-01 2024-12-31 07318073 core:MotorVehicles 2024-01-01 2024-12-31 07318073 bus:RegisteredOffice 2024-01-01 2024-12-31 07318073 bus:LeadAgentIfApplicable 2024-01-01 2024-12-31 07318073 bus:Director2 2024-01-01 2024-12-31 07318073 bus:Director1 2024-01-01 2024-12-31 07318073 core:WithinOneYear 2024-12-31 07318073 core:WithinOneYear 2023-12-31 07318073 core:AfterOneYear 2024-12-31 07318073 core:AfterOneYear 2023-12-31 07318073 core:ShareCapital 2024-12-31 07318073 core:ShareCapital 2023-12-31 07318073 core:RetainedEarningsAccumulatedLosses 2024-12-31 07318073 core:RetainedEarningsAccumulatedLosses 2023-12-31 07318073 bus:Director2 2023-12-31 07318073 bus:Director2 2024-12-31 07318073 bus:Director1 2022-12-31 07318073 bus:Director2 2022-12-31 07318073 bus:Director2 2023-12-31 07318073 bus:Director1 2023-01-01 2023-12-31 07318073 bus:Director2 2023-01-01 2023-12-31 07318073 bus:SmallEntities 2024-01-01 2024-12-31 07318073 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 07318073 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 07318073 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 07318073 bus:AbridgedAccounts 2024-01-01 2024-12-31
COMPANY REGISTRATION NUMBER: 07318073
Lynchwood Diagnostics Limited
Filleted Unaudited Abridged Financial Statements
31 December 2024
Lynchwood Diagnostics Limited
Abridged Financial Statements
Year Ended 31 December 2024
Contents
Pages
Officers and professional advisers
1
Abridged statement of financial position
2 to 3
Notes to the abridged financial statements
4 to 6
Lynchwood Diagnostics Limited
Officers and Professional Advisers
Director
Mr P Bates
Registered office
88 High Street
Ramsey
Huntingdon
Cambs
PE26 1BS
Accountants
SR Howell & Co
Chartered Certified Accountants
88 High Street
Ramsey
Huntingdon
Cambs
PE26 1BS
Lynchwood Diagnostics Limited
Abridged Statement of Financial Position
31 December 2024
2024
2023
Note
£
£
Fixed assets
Tangible assets
5
1,203
2,542
Current assets
Stocks
10,609
12,609
Debtors
6,313
9,493
Cash at bank and in hand
1,199
63
--------
--------
18,121
22,165
Creditors: amounts falling due within one year
( 23,986)
( 40,341)
--------
--------
Net current liabilities
( 5,865)
( 18,176)
-------
--------
Total assets less current liabilities
( 4,662)
( 15,634)
Creditors: amounts falling due after more than one year
( 1,950)
( 6,009)
-------
--------
Net liabilities
( 6,612)
( 21,643)
-------
--------
Capital and reserves
Called up share capital
1,300
1,300
Profit and loss account
( 7,912)
( 22,943)
-------
--------
Shareholders deficit
( 6,612)
( 21,643)
-------
--------
These abridged financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the abridged statement of income and retained earnings has not been delivered.
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its abridged financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of abridged financial statements .
All of the members have consented to the preparation of the abridged statement of income and retained earnings and the abridged statement of financial position for the year ending 31 December 2024 in accordance with Section 444(2A) of the Companies Act 2006.
Lynchwood Diagnostics Limited
Abridged Statement of Financial Position (continued)
31 December 2024
These abridged financial statements were approved by the board of directors and authorised for issue on 22 July 2025 , and are signed on behalf of the board by:
„„„„„„„„„„„„„
Mr P Bates Director
Company registration number: 07318073
Lynchwood Diagnostics Limited
Notes to the Abridged Financial Statements
Year Ended 31 December 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 88 High Street, Ramsey, Huntingdon, Cambs, PE26 1BS.
2. Statement of compliance
These abridged financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
3.1 Basis of preparation
The abridged financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The abridged financial statements are prepared in sterling, which is the functional currency of the entity.
3.2 Revenue recognition
Turnover comprises the invoice value of goods and services supplied by the company during the year, net of Value Added Tax and trade discounts.
3.3 Foreign currencies
Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the profit and loss account.
3.4 Tangible assets
Tangible fixed assets are stated at cost less depreciation.
3.5 Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Plant & machinery
-
25% reducing balance
Motor vehicle
-
25% reducing balance
3.6 Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
3.7 Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 3 (2023: 3 ).
5. Tangible assets
£
Cost
At 1 January 2024
16,348
Additions
1,175
Disposals
( 10,090)
--------
At 31 December 2024
7,433
--------
Depreciation
At 1 January 2024
13,806
Charge for the year
369
Disposals
( 7,945)
--------
At 31 December 2024
6,230
--------
Carrying amount
At 31 December 2024
1,203
--------
At 31 December 2023
2,542
--------
6. Director's advances, credits and guarantees
During the year the director entered into the following advances and credits with the company:
2024
Balance brought forward
Amounts repaid
Balance outstanding
£
£
£
Mr A Pattison
Mr P Bates
( 5,601)
4,917
( 684)
-------
-------
----
( 5,601)
4,917
( 684)
-------
-------
----
2023
Balance brought forward
Amounts repaid
Balance outstanding
£
£
£
Mr A Pattison
( 1,700)
1,700
Mr P Bates
( 826)
( 4,775)
( 5,601)
-------
-------
-------
( 2,526)
( 3,075)
( 5,601)
-------
-------
-------
The above loan is unsecured, interest free and repayable on demand.